Contineum Therapeutics CTNM
NASDAQ CTNM
$8.46 +1.02 (+13.71%)
At close: Oct 20, 2026 · 4:00 PM EDT

Contineum Therapeutics (CTNM) Revenue (2023)

Updated

Contineum Therapeutics (CTNM) recorded Revenue of $50 million in FY2023.

Analysis

Contineum Therapeutics (CTNM) Revenue (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 25.31 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 16.99 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 15.38 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 7.80 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 15.03 Bn
10 Contineum Therapeutics 316.60 Mn -611.58 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 50.00 Mn
API Access

Contineum Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=CTNM&period=max&api_key=YOUR_API_KEY